NEW YORK (GenomeWeb News) — Roche e today said it has sold a 454 Life Sciences GS20 sequencer to the South African company Inqaba Biotechnical Industries. The deal includes the option to upgrade to a GS FLX.
 
Roche Diagnostics said it will provide Inqaba with support for the GS20’s applications.  
 
Inqaba said it was supported by BioPAD, a South African government-funded trust and shareholder designed to create a sequencing service in the region.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.